Standard BioTools 2023 Investor Presentation | Life Science Tools

Standard BioTools Inc. (formerly Fluidigm Corporation) is a life science tools company serving pharma research markets with products including CyTOF, Hyperion, and imaging mass cytometry platforms. The presentation outlines the company's strategic vision for building a diversified, innovation-focused platform through M&A, leveraging a $250 million capital infusion from investors Casdin Capital and Viking Global.